Rigel Pharmaceuticals recently announced the enrollment of the first patient in the dose expansion phase of its ongoing Phase 1b study of R289 in relapsed or refractory lower-risk myelodysplastic ...

President Trump gave an update on his youngest son Barron’s progress at New York University shortly before the first son started his sophomore year at a satellite campus in Washington, DC. Trump ...

Almost a year to the day after Roche pulled out a partnership on its underperforming cancer therapy Gavreto, Blueprint Medicines has sold US commercial rights to the drug to Rigel Pharma in a deal ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...

Against the backdrop of an unseen centuries-old war between the sophisticated Vampire clan and the brutish clan of lycanthropes, the Lycans, the lethally alluring vampire assassin and member of the ...

Chart does not reflect overnight price.

Rigel Chemicals Private Limited is an Indian Non-Government Company. It's a private company and is classified as'company limited by shares'. Company's authorized capital stands at Rs 5.0 lakhs and has ...

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology.